Role of Quantitative Magnetic Resonance Imaging Parameters in the Evaluation of Treatment Response in Malignant Tumors
暂无分享,去创建一个
[1] N. Hylton,et al. MRI in breast cancer therapy monitoring , 2011, NMR in biomedicine.
[2] Peter Gibbs,et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. , 2006, Magnetic resonance imaging.
[3] William E Grizzle,et al. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. , 2008, Radiology.
[4] C. Kim,et al. Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion‐weighted MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[5] R. Gillies,et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. , 2004, Neoplasia.
[6] D. Choi,et al. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results. , 2012, The British journal of radiology.
[7] A. Jackson,et al. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies , 2012, Nature Reviews Clinical Oncology.
[8] K. Verstraete,et al. Bone and soft tissue tumors: the role of contrast agents for MR imaging. , 2000, European journal of radiology.
[9] T. Hirai,et al. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient , 2010, Skeletal Radiology.
[10] T. Murakami,et al. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. , 1999, AJR. American journal of roentgenology.
[11] Milica Medved,et al. Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time , 2004, Journal of magnetic resonance imaging : JMRI.
[12] C. Kim,et al. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. , 2010, AJR. American journal of roentgenology.
[13] Jun Li,et al. A clinically feasible method to estimate pharmacokinetic parameters in breast cancer. , 2009, Medical physics.
[14] Sanjeev Chawla,et al. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. , 2013, AJR. American journal of roentgenology.
[15] G. Bollini,et al. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results , 2012, Skeletal Radiology.
[16] Marcelino Bernardo,et al. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. , 2010, Diagnostic and interventional radiology.
[17] Thomas E Yankeelov,et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.
[18] L. Bassett,et al. Combined DCE‐MRI and single‐voxel 2D MRS for differentiation between benign and malignant breast lesions , 2010, NMR in biomedicine.
[19] R. Hermans,et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma , 2010, European Radiology.
[20] G. Weinstein,et al. Prediction of Disease-Free Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging , 2011, American Journal of Neuroradiology.
[21] G. Weinstein,et al. Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck , 2009, Clinical Cancer Research.
[22] G. Weinstein,et al. Prediction of Response to Chemoradiation Therapy in Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging , 2010, American Journal of Neuroradiology.
[23] S. Takashima,et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. , 2001, Radiology.
[24] J. Xian,et al. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors , 2014, Chinese medical journal.
[25] Clare Allen,et al. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy , 2010, BJU international.
[26] B. K. Park,et al. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. , 2008, AJR. American journal of roentgenology.
[27] Ann D. King,et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response , 2010, European Radiology.
[28] A. Padhani. Integrating multiparametric prostate MRI into clinical practice , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.
[29] Marek Ancukiewicz,et al. Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy , 2013, Journal of Hematology & Oncology.
[30] Qing Ji,et al. Dynamic contrast‐enhanced magnetic resonance imaging as a prognostic factor in predicting event‐free and overall survival in pediatric patients with osteosarcoma , 2012, Cancer.
[31] Jean-Luc Daire,et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. , 2003, Radiology.
[32] J P Logue,et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] T. Ishidate,et al. Changes in Diffusion-Weighted Images for Visualizing Prostate Cancer during Antiandrogen Therapy: Preliminary Results , 2010, Urologia Internationalis.
[34] D. Collins,et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. , 2007, AJR. American journal of roentgenology.
[35] T. Martín Noguerol,et al. Utility of MRI Diffusion Techniques in the Evaluation of Tumors of the Head and Neck , 2013, Cancers.
[36] N. Hylton. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] David A Bluemke,et al. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. , 2009, Radiology.
[38] Fiona J Gilbert,et al. Use of new imaging techniques to predict tumour response to therapy. , 2010, The Lancet. Oncology.
[39] L. Shen,et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. , 2008, Radiology.
[40] Katarzyna J Macura,et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.
[41] T. M. Noguerol,et al. Utility of MRI Diffusion Techniques in the Evaluation of Tumors of the Head and Neck , 2013 .
[42] J. Gore,et al. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. , 2005, Magnetic resonance imaging.
[43] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[44] James H Thrall,et al. Imaging angiogenesis: applications and potential for drug development. , 2005, Journal of the National Cancer Institute.
[45] Bradford A Moffat,et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. , 2009, Translational oncology.
[46] M. Sumi,et al. Multiparametric MR Imaging of Sinonasal Diseases: Time-Signal Intensity Curve– and Apparent Diffusion Coefficient–Based Differentiation between Benign and Malignant Lesions , 2011, American Journal of Neuroradiology.
[47] G. Parker,et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.
[48] Jan Wolber,et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation , 2002, The Lancet.
[49] Arend Heerschap,et al. Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use? , 2012, Critical reviews in oncology/hematology.
[50] Hee Jung Shin,et al. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS , 2012, NMR in biomedicine.
[51] U. Sharma,et al. Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy , 2009, NMR in biomedicine.
[52] Anwar R. Padhani,et al. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy , 2010, Targeted Oncology.
[53] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[54] Jie Li,et al. DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy , 2011, Medical Oncology.
[55] M. Knopp,et al. Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.
[56] Brian D Ross,et al. Predicting and monitoring cancer treatment response with diffusion‐weighted MRI , 2010, Journal of magnetic resonance imaging : JMRI.
[57] G Brix,et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. , 2001, Cancer research.
[58] Bradford A Moffat,et al. Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer Chemotherapy , 2007, Clinical Cancer Research.
[59] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[60] Hidetake Yabuuchi,et al. Index terms: , 2002 .